首页> 外文期刊>International Journal of Chronic Obstructive Pulmonary Disease >Enhanced External Counterpulsation Efficacy on Exercise Endurance in COPD Patients and Healthy Subjects: A Pilot Randomized Clinical Trial
【24h】

Enhanced External Counterpulsation Efficacy on Exercise Endurance in COPD Patients and Healthy Subjects: A Pilot Randomized Clinical Trial

机译:增强COPD患者锻炼效果的外部逆水疗效和健康受试者:试点随机临床试验

获取原文
           

摘要

Purpose: Enhanced external counterpulsation (EECP) is popular in China for the treatment of coronary heart diseases, but it may be an effective treatment for other populations. This study aimed to explore the effect of EECP on exercise endurance of healthy people and chronic obstructive pulmonary disease (COPD) patients and provide intervention measures to improve their physical condition. Patients and methods: Patients were enrolled in this pilot randomized controlled trial at Jiangbin Hospital, China, between March 1st and May 30th, 2018. They were randomly divided into the EECP and non-EECP groups. According to their maximal oxygen uptake, the volunteers were also sub-grouped into the normal, low exercise endurance, and COPD subgroups. Differences in exercise endurance were evaluated between the EECP and non-EECP groups before and after treatment. Cardiopulmonary exercise testng included anaerobic threshold oxygen uptake (AT-VOsub2/subKg), maximum oxygen uptake (Max-VOsub2/subKg), anaerobic threshold pulse (AT-Osub2/subpuls), anaerobic threshold metabolic equivalent (AT-Mets), and maximum metabolic equivalent (Max-Mets). Results: 72 volunteers were enrolled. The EECP and non-EECP groups were similar in terms of age, sex, body mass index, blood pressure, heart rate, breathing frequency, AT-VOsub2/subKg, Max-VOsub2/subKg, AT-Osub2/subpuls, AT-Mets, and Max-Mets (P 0.05) before treatment. EECP significantly improved AT-VOsub2/subKg, Max-VOsub2/subKg, AT-Osub2/subpuls, AT-Mets, and Max-Mets compared with the non-EECP group (P0.05). When analyzed according to sub-groups, the AT-VOsub2/subKg, Max-VOsub2/subKg, AT-Osub2/subpuls, AT-Mets, and Max-Mets of the normal, low exercise endurance, and COPD subgroups were all significantly increased after EECP (P0.05). Conclusion: EECP significantly improved the exercise endurance of normal adults, low endurance adults, and COPD patients. Registration number: ChiCTR1900021993.
机译:目的:增强的外部逆水(EECP)在中国很受欢迎,用于治疗冠心病疾病,但它可能是对其他人群的有效治疗方法。本研究旨在探讨EECP对健康人和慢性阻塞性肺病(COPD)患者的锻炼耐力的影响,并提供干预措施以改善其身体状况。患者和方法:患者于2018年3月1日和5月30日在中国江滨医院注册了该试点随机对照试验。他们随机分为EECP和非EECP组。根据其最大氧气摄取,志愿者也分为正常,低的锻炼耐久性和COPD亚组。在治疗之前和之后,在EECP和非EECP组之间评估锻炼耐久性的差异。心肺锻炼Testng包括厌氧阈值氧吸收(AT-VO 2 kg),最大氧吸收(MAX-VO 2 kg),厌氧阈值脉冲(AT-O 2 脉冲),厌氧阈值代谢等效物(at-mets),以及最大代谢等效物(MAX-MET)。结果:注册了72名志愿者。 EECP和非EECP组在年龄,性别,体重指数,血压,心率,呼吸频率,vo 2 kg,max-vo 2 < / kg,kg,AT-O 2 脉冲,在处理之前,在MET和MAX-MET(P> 0.05)。 EECP在-VO 2 kg,max-vo 2 kg,at-o 2 puls,at-met和max-met中得到了显着改善与非EECP组相比(P <0.05)。当根据子组分析时,AT-VO 2 kg,max-vo 2 kg,AT-O 2 脉冲,AT- Mets和Max-Mets的正常,低锻炼耐久性和COPD亚组在EECP(P <0.05)后都显着增加。结论:EECP显着提高了正常成人,低耐力成人和COPD患者的锻炼耐力。注册号:CHICTR1900021993。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号